رجوع
44
نطاق اليوم
KWD 80.54
KWD 82.46
نطاق 52 أسبوعًا
KWD 72.76
KWD 116.65
حجم التداول
748,070
متوسط 50 يوم / 200 يوم
KWD 80.99
/
KWD 92.37
الإغلاق السابق
KWD 81.02
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (626 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 32.4 | 0.4 |
| P/B | 3.3 | 2.9 |
| ROE % | 10.2 | 3.7 |
| Net Margin % | 16.4 | 3.8 |
| Rev Growth 5Y % | 14.8 | 10.0 |
| D/E | 0.5 | 0.2 |
النقاط الرئيسية
Revenue grew 14.79% annually over 5 years — strong growth
Earnings grew 122.54% over the past year
ROE of 10.19% — decent returns on equity
Net margin of 16.38% shows strong profitability
Debt/Equity of 0.48 — conservative balance sheet
Generating 455.13M in free cash flow
النمو
Revenue Growth (5Y)
14.79%
Revenue (1Y)9.47%
Earnings (1Y)122.54%
FCF Growth (3Y)52.09%
الجودة
Return on Equity
10.19%
ROIC7.78%
Net Margin16.38%
Op. Margin24.55%
الأمان
Debt / Equity
0.48
Current Ratio3.27
Interest Coverage5.64
التقييم
P/E Ratio
32.41
P/B Ratio3.31
EV/EBITDA23.75
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 9.47% | Revenue Growth (3Y) | 14.63% |
| Earnings Growth (1Y) | 122.54% | Earnings Growth (3Y) | 96.54% |
| Revenue Growth (5Y) | 14.79% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1.31B | Net Income (TTM) | 215.20M |
| ROE | 10.19% | ROA | 6.27% |
| Gross Margin | 69.52% | Operating Margin | 24.55% |
| Net Margin | 16.38% | Free Cash Flow (TTM) | 455.13M |
| ROIC | 7.78% | FCF Growth (3Y) | 52.09% |
| Safety | |||
| Debt / Equity | 0.48 | Current Ratio | 3.27 |
| Interest Coverage | 5.64 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 32.41 | P/B Ratio | 3.31 |
| P/S Ratio | 5.31 | PEG Ratio | 0.27 |
| EV/EBITDA | 23.75 | Dividend Yield | 0.00% |
| Market Cap | 6.98B | Enterprise Value | 7.66B |
Income Statement
Annual, most recent first
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 1.31B | 1.20B | 999.59M | 861.75M | 756.56M |
| Net Income | 215.20M | 96.70M | 55.71M | -26.14M | -44.29M |
| EPS (Diluted) | 2.46 | 1.09 | 0.64 | -0.31 | -0.53 |
| Gross Profit | 913.12M | 692.58M | 529.87M | 395.51M | 340.92M |
| Operating Income | 322.46M | 230.07M | 128.13M | 37.65M | 40.57M |
Balance Sheet
Annual, most recent first
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Total Assets | 3.43B | 3.45B | 3.16B | 3.09B | 3.11B |
| Total Liabilities | 1.32B | 1.33B | 1.13B | 1.19B | 1.25B |
| Shareholders' Equity | 2.11B | 2.11B | 2.04B | 1.90B | 1.85B |
| Total Debt | 1.00B | 1.11B | 933.14M | 994.49M | 1.01B |
| Cash & Equivalents | 318.93M | 295.95M | 403.98M | 254.27M | 225.41M |
| Current Assets | 512.28M | 477.75M | 557.44M | 382.89M | 351.34M |
| Current Liabilities | 156.85M | 156.32M | 117.09M | 131.06M | 153.19M |
درجات الاستراتيجيات
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#546 of 1024
النشاط الأخير
دخل
Cash Flow Compounder
Mar 24, 2026